A former Marijuana Policy Project leader challenges the group's support for legal hemp intoxicants, spotlighting regulatory splits and their impact on the DMV weed market.

Georgia’s medical cannabis program is expanding even as state regulators wait for input from the DEA. Here’s why it matters and what DMV readers should watch.

MJBizDaily reports cannabis multistate operators have given millions to President Donald Trump’s PACs, which may fund a staunchly anti-cannabis Senate hopeful. Here’s what it could mean.

Anti-marijuana groups and a pharma company asked a D.C. appeals court to revive their challenge to a Medicare initiative that lets providers furnish certain hemp-derived CBD products to beneficiaries.

Treasury and the IRS say tax guidance tied to cannabis rescheduling is a top priority for 2026–2027, with big implications for Section 280E and mixed medical/adult-use operators.

A late-2025 federal shift caps total THC in hemp products at 0.4 mg per container starting December 11, forcing retailers to pull common CBD edibles and tinctures—and raising urgent questions for DMV consumers.

Four Republican senators signaled no interest in rethinking a looming federal clampdown on hemp-derived cannabinoids, citing alleged Chinese involvement, per MJBizDaily.

A DEA administrative law judge halted the federal rescheduling proceeding to weigh a new GAO report on agency procedures—delaying a final ruling and keeping the status quo in place for now.

A bipartisan House bill would require the U.S. Department of Veterans Affairs to examine medical marijuana for PTSD and chronic pain—starting with an observational study.

Rescheduling momentum is real, but tax experts say cannabis businesses may remain under 280E for the entire 2025 tax year. Here’s what that means for DMV operators and delivery services.

A DEA administrative judge paused the cannabis rescheduling hearing to consider a GAO watchdog report on process gaps. A DEA response is due by October 13, adding delay and uncertainty.

DEA released the marijuana rescheduling hearing transcript as ALJ Derek Julius weighs a Schedule III recommendation. Here’s what it could mean for DMV delivery compliance.

A new Nebraska Senate ad spotlights Pete Ricketts’s past line that legalization would “kill your kids,” while federal stances on rescheduling, 280E and banking keep delivery rules in flux.

Federal lobbying hit record highs in Q2 2026 while the DEA targets tryptamines and Oregon reconsiders psilocybin program fees.

Marijuana Moment obtained DEA’s 26-question list for Colorado medical operators seeking federal rescheduling protections. Here’s why it matters for delivery, transport and compliance in the DMV.

The federal bill would shield banks that serve state‑sanctioned cannabis businesses and hemp/CBD, require FinCEN‑guided compliance, and leave service decisions to each bank.

Despite state-legal markets, many licensed operators still struggle to bank. Here’s how Pima Federal Credit Union built a compliant program—and what it means for delivery.

Cannabis Wire reports uncertainty over a potential federal ban later this year. Here’s what DMV delivery operators and consumers should watch and how to plan.

Discover how interning with NORML builds hands-on skills in cannabis policy, legal reform, and grassroots advocacy for future industry leaders.

DEA released thousands of pages from an 11-day July hearing on cannabis rescheduling. Here’s what was published, what’s still unknown, and how DMV readers should track it.